KIRAN NAQVI to Biomarkers
This is a "connection" page, showing publications KIRAN NAQVI has written about Biomarkers.
Connection Strength
0.103
-
Extensive ulcerated lesions in a patient with cutaneous myeloid sarcoma responded to twice-daily fludarabine and cytarabine regimen. Blood Cells Mol Dis. 2018 03; 69:43-44.
Score: 0.066
-
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality. Leukemia. 2020 11; 34(11):2914-2924.
Score: 0.021
-
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy. Am J Hematol. 2016 12; 91(12):1221-1226.
Score: 0.016